Literature DB >> 8968031

Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats.

S Williams1, A Wakisaka, Q Q Zeng, J Barnes, G Martin, W J Wechter, C T Liang.   

Abstract

In the current study, we examined the effects of minocycline, on the osteopenia of ovariectomized aged rats. Old female rats were randomly divided into five groups: sham, ovariectomized control and ovariectomized treated with minocycline, 17beta-estradiol, or both agents. Bone samples were collected 8 wk after the treatment. Ovariectomy reduced bone mineral density of the whole femur and at the condylar, distal metaphyseal and head-neck-trochanter regions 10%-19% and the loss of bone density was prevented by treatment with minocycline or 17beta-estradiol. Histomorphometric analysis of distal femur showed ovariectomy reduced the trabecular bone area, the trabecular bone number, trabecular bone thickness and increased the trabecular bone separation. The microanatomic structure of trabecular bone also showed that the number of nodes, node to node, cortical to node, node to free end was reduced by ovariectomy. Treatment with minocycline attenuated the effect of ovariectomy on trabecular bone in aged animals. In contrast, cortical bone was not affected by ovariectomy or minocycline treatment. The effect of minocycline on bone turnover was also examined. Minocycline increased osteoid surface, mineralizing surface, mineral apposition rate, bone formation rate and reduced eroded surface. We have therefore concluded that the modest increase in bone mineral density and the improvement in the trabecular bone status noted in minocycline treated ovariectomized aged rats is likely due to an increase in bone formation coupled with a decrease in bone resorption.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968031     DOI: 10.1016/s8756-3282(96)00302-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  24 in total

1.  Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders.

Authors:  H Cohen; V Solomon; I S Alferiev; E Breuer; A Ornoy; N Patlas; N Eidelman; G Hägele; G Golomb
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

2.  Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.

Authors:  Gilson C N Franco; Mikihito Kajiya; Tadashi Nakanishi; Kouji Ohta; Pedro L Rosalen; Francisco C Groppo; Cory W O Ernst; Janie L Boyesen; John D Bartlett; Philip Stashenko; Martin A Taubman; Toshihisa Kawai
Journal:  Exp Cell Res       Date:  2011-03-21       Impact factor: 3.905

3.  Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone.

Authors:  Jeffry S Nyman; Conor C Lynch; Daniel S Perrien; Sophie Thiolloy; Elizabeth C O'Quinn; Chetan A Patil; Xiaohong Bi; George M Pharr; Anita Mahadevan-Jansen; Gregory R Mundy
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

Review 4.  Bone Remodeling and the Microbiome.

Authors:  Roberto Pacifici
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 5.  Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic.

Authors:  Jeffrey B Payne; Lorne M Golub
Journal:  Pharmacol Res       Date:  2010-10-16       Impact factor: 7.658

6.  Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women.

Authors:  Jeffrey B Payne; Julie A Stoner; Pirkka V Nummikoski; Richard A Reinhardt; Arthur D Goren; Mark S Wolff; Hsi-Ming Lee; James C Lynch; Robert Valente; Lorne M Golub
Journal:  J Clin Periodontol       Date:  2007-09       Impact factor: 8.728

7.  Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women.

Authors:  Lorne M Golub; Hsi Ming Lee; Julie A Stoner; Timo Sorsa; Richard A Reinhardt; Mark S Wolff; Maria E Ryan; Pirkka V Nummikoski; Jeffrey B Payne
Journal:  J Periodontol       Date:  2008-08       Impact factor: 6.993

Review 8.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

9.  Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute.

Authors:  Jianwen Xu; Xinning Li; Jane B Lian; David C Ayers; Jie Song
Journal:  J Orthop Res       Date:  2009-10       Impact factor: 3.494

Review 10.  From Osteoimmunology to Osteomicrobiology: How the Microbiota and the Immune System Regulate Bone.

Authors:  Emory Hsu; Roberto Pacifici
Journal:  Calcif Tissue Int       Date:  2017-10-10       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.